Advancing personalized care and innovative research for patients with inherited heart diseases.
Managed over 5,000 patient cases in the fields of cardiogenetics and oncogenetics
Through cutting-edge research and personalized patient care, we're transforming the future of inherited cardiac disorder treatment and genetic counseling.
Dr. Mohamed El Hachmi is a Cardiogeneticist specializing in Precision Medicine, with dual PhDs from Sapienza University of Rome and Paris Cité University. His research focuses on rare inherited heart diseases, with particular expertise in Hypertrophic Cardiomyopathy (HCM), Vascular Ehlers-Danlos Syndrome (vEDS), and Cardiac Amyloidosis (ATTR).
Sapienza University of Rome & Paris Cité University
European Board of Medical Genetics (EBMG)
Hôpital Européen Georges Pompidou, Paris
Leading the GEREMY Registry for genetic profiling and precision treatment eligibility in HCM patients. Developing risk stratification models based on genetic variants.
HCM causes the heart muscle to thicken, making it harder to pump blood. We're studying genetic factors to improve treatment options and predict who may develop symptoms.
Comprehensive research on genetic and phenotypic determinants of disease progression in dilated cardiomyopathy, with specialized focus on laminopathies and neuromuscular cardiomyopathies.
We study inherited forms of dilated cardiomyopathy to identify high-risk patients early and develop personalized treatment strategies to prevent complications.
Expert diagnosis, risk stratification and management of this complex disease using multidisciplinary approach integrating clinical assessment, advanced imaging and cardiovascular genetics.
ACM is a rare inherited heart condition that can cause dangerous heart rhythms. We work to identify patients at risk and provide personalized care to prevent sudden cardiac events.
Expert Lead: Dr. El Hachmi – Genetic Counselling & PRS Specialist. Recognized expertise in integrating PRS into personalized cardiovascular prevention, focusing on atrial fibrillation, coronary artery disease, and hypercholesterolemia.
If you have a family history of cardiovascular disease or have received an early diagnosis, PRS testing may help you understand your genetic risk profile and support more personalized treatment decisions.
Stay updated with our latest research publications and clinical developments
Explore our comprehensive chapter on cardiac involvement with or without myopathy in the prestigious Encyclopedia of the Neurological Sciences, Third Edition. This authoritative reference covers major advances in neurobiology and clinical neurosciences.
Dr. El Hachmi joins international consortium for cardiogenetics research
January 2025French HCM registry reaches 1,500 enrolled patients
December 2024Breakthrough findings in vEDS treatment published
November 2024Follow our research updates and clinical developments
Circulation
Read more →International Journal of Cardiology
Read more →Circulation: Genomic and Precision Medicine
Read more →Dr. El Hachmi is actively looking for research partners in multicenter studies, cohort data sharing, and genetic screening programs for inherited cardiac disorders.